-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes AnaptysBio at Buy, Announces Price Target of $95

Benzinga·06/10/2026 10:20:13
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis assumes AnaptysBio (NASDAQ:ANAB) with a Buy rating and announces Price Target of $95.